REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome
for Angelman Syndrome
17 locations incl. Los Angeles
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All·Age: 2 - 50
Code: NCT06914609·Phase 3·Recruiting·Listed Apr 2025
University of North Carolina - Chapel Hill
Clinical research site in Carrboro, North Carolina · 200 N GREENSBORO ST, SUITE C-6A, CARRBORO, NC 27510-1833 · (919) 942-7363
Part of UNC Chapel Hill
As of July 2026, 4 paid clinical trials are recruiting at University of North Carolina - Chapel Hill in Carrboro, North Carolina. Active studies at this site focus on Angelman Syndrome alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at University of North Carolina - Chapel Hill (4)
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
for Angelman Syndrome
5 locations incl. San Diego
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All·Age: 0 - 50
Code: NCT05127226·Phase 1, Phase 2·Recruiting·Listed Nov 2021
Health Education Approach to Lung Screening
for Lung Cancer
3 locations incl. Carrboro
Sponsor: Virginia Commonwealth University
Sex: All·Age: 50 - 80·Accepts healthy volunteers
Code: NCT06070870·Recruiting·Listed Oct 2023
STRW-T Intervention for Autistic Adolescents in 11th and 12th Grade
for Autism Spectrum Disorder
2 locations incl. Carrboro
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All·Age: 15 - 21
Code: NCT06552286·Recruiting·Listed Aug 2024
More research sites in Carrboro
Explore more
Paid clinical trials in Carrboro, NC · North Carolina clinical trials